Skip to main content

You are leaving IngeniumCanada.org

This link leads to an external website that Ingenium does not control. Please read the third-party’s privacy policies before entering personal information or conducting a transaction on their site.

Have questions? Review our Privacy Statement

Vous quittez IngeniumCanada.org

Ce lien mène à un site Web externe qu'Ingenium ne contrôle pas. Veuillez lire les politiques de confidentialité des tiers avant de partager des renseignements personnels ou d'effectuer une transaction sur leur site.

Questions? Consultez notre Énoncé de confidentialité

Langue

Français

Search

Menu des liens rapides

Ingenium Locations
Shop
Donate
Join

Menu

Main Navigation

Browse
About
- About The Channel
- Content Partners

Explore

Browse

Article

Read original articles as well as short summaries with links to our favourite online sources.

Filters

Clear All

Categories

Publication

BBC - Home (1)
BBC - Homepage (1)
CBC.ca (1)
National Post (1)
The Washington Post (1)
University of Toronto Libraries (1)

Reading Duration

Short (21)
Medium (4)
Long (5)

155 Results:

Sort by

Stephen Scherer

Getting to the root of autism

Canada Foundation for Innovation

SickKids researcher Stephen Scherer offers parents an explanation of the genetic causes of autism By Christopher Pollon To hear Stephen Scherer tell it, his path to becoming director of The Centre for Applied Genomics at Toronto’s Hospital for Sick Children (SickKids) and one of the world’s most accomplished autism researchers was pure serendipity. It was the late 1990s, and Scherer was a staff scientist at SickKids working as part of the Human Genome Project, mapping and sequencing chromosome 7

Ray Rajotte & James Shapiro: Paving the road for a cure for Type 1 diabetes

Ray Rajotte, James Shapiro: Focused on curing Type 1 diabetes

University of Alberta

Canadian researchers have always been at the forefront of diabetes research, starting with insulin’s discovery in 1921. The next giant leap forward was the Edmonton Protocol in 1999—a major breakthrough towards a cure for the 2 million+ Canadians, and 30 million globally, Type 1 diabetics. The disease stops the pancreas producing insulin, an important hormone that helps you get energy from food. Insulin injections help Type 1 diabetics stay alive, but it’s not cure. Nor does it always prevent

Roberta Bondar posing for a photo [Bryan Adams / Bibliothèque et Archives Canada / numéro de référence archivistique R11443-11]

Dr. Roberta Bondar

Beginning of Bondar Roberta Bondar was born in Sault Ste. Marie, Ontario. She spent time conducting science experiments in her basement laboratory that her father built for her and loved the science fairs at her school. She also went to high school there before eventually leaving for a lengthy post-secondary education. Her accolades in school include: Bachelor of Science degree in zoology and agriculture from the University of Guelph in 1968 Master of Science degree in experimental pathology

new drug development technology

Household Technology

Changing the shape of drug delivery

Canada Foundation for Innovation

A University of Toronto spin-off finds success in commercializing new drug development technology By Malorie Bertrand Like a sculptor to clay, organic chemist Andrei Yudin and his team manipulate the shape of large molecules using chemical reactions to make them orally absorbable. Complex molecules that perform sophisticated tasks to treat certain diseases are typically too big to be orally absorbed such as smaller, simpler molecules, such as Aspirin. With the help of equipment funded by the

Dr. Gabor Maté: Dislocation and the Treatment of Addictions

Dr. Gabor Maté: Dislocation and the Treatment of Addictions

Canadian Museum of Immigration at Pier 21

Gabor Maté left Hungary with his family in 1956 as part of the refugee exodus following the October revolt against the regime. His family also experienced anti-semitism during that time. Gabor and his family immigrated to Vancouver, where Gabor felt “like a fish out of water” as a thirteen-year-old who had absorbed the history, culture and “historical angst” of Eastern Europe. As a physician working in the area of addictions, Dr. Maté spent twelve years working in Vancouver’s Downtown East side

Dr. Abdul Shukkoor

Dr. Abdul Shukkoor and the Edmonton Injector

Canadian Museum of Immigration at Pier 21

Dr. Abdul Shukkoor is from Kerala, India, and worked in palliative care in Lethbridge at the time of the interview (May, 2014). He initially came to Canada from Saudi Arabia, where he became involved with end-of-life care through his work with cancer patients. After researching several countries where hospice and end-of-life research was being carried out, he decided to go to Edmonton, which had “one of the famous programs in the world.” In Edmonton (and Texas) he was involved in a research

Going nano to revolutionize burn and wound care

Going nano to revolutionize burn and wound care

University of Alberta

In the 1990s, Robert Burrell began the research that would revolutionize wound and burn care. While research director at Alberta’s Westaim Biomedical, Burrell saw the potential for nanotechnology in medical applications. Working with the University of Alberta, he developed a nanostructured silver bandage called Acticoat™—the world’s first therapeutic application of nanotechnology. A silver bullet against bacterial infection Silver has been used as an antibacterial agent since the late 1800s. In

Acticoat™ – One of world’s biggest advances in burn/wound care

Acticoat™ - One of world's biggest advances in burn/wound care

University of Alberta

Acticoat™ has saved the lives and limbs of thousands of people around the world and dramatically improved burn and chronic wound care. The nanostructured silver bandage is considered to be the world’s first therapeutic application of nanotechnology. In the 1990s, Robert Burrell saw the potential to apply nanotechnology to medicine. As research director at Alberta’s Westaim Biomedical and working with the University of Alberta, Burrell developed the nanocrystalline structure that unlocked the

Jack Hopps, at the controls, and Ray Charbonneau, an NRC technician who built several biomedical devices at the NRC, in Ottawa, ca 1951. Source: National Research Council of Canada Archives

Engineering & Technology

Cardiac Pacemaker

Ingenium – Canada's Museums of Science and Innovation

The pacemaker is a Canadian invention that keeps hearts beating. The pacemaker revolutionized the medical treatment of cardiac patients — and kick-started the field of biomedical engineering. In the late 1940s, Canadian surgeons Dr. Wilfred G. Bigelow and Dr. John C. Callaghan were exploring open-heart surgery techniques at the University of Toronto’s Banting and Best Institute. Based on his wartime experience as a medic, Bigelow hypothesized that cooling the body and slowing the heart rate

Michael Smith was a Canadian biochemist and businessman.

Michael Smith brings Canada to the forefront of genetic technology

Algonquin college

Bryson Masse At age 11, Michael Smith did remarkably well in his eleven plus exam – a test administered in England that separates the top 20 per cent of students from the rest. Those in this small category could receive a higher academic education that the others could not. Smith’s option was the Arnold School for Boys. But going to this school meant losing his old friends, eating war-time lunches and playing sports he had no interest in. Luckily for us, Smith did choose to go – a move that sent

Page

First page
…
Page 7
Page 8
Page 9
Page 10
Current page 11
Page 12
Page 13
Page 14
Page 15
…
Last page

Footer

About The Channel

Contact Us

Ingenium
P.O. Box 9724, Station T
Ottawa ON K1G 5A3
Canada

contact@IngeniumCanada.org

Facebook
Instagram
Twitter

Channel
Visit
Ingenium
For Media
- Newsroom
- Awards

Connect with us

Subscribe to our newsletter to receive the latest Ingenium news straight to your inbox!

Legal Bits

Privacy Statement

© 2025 Ingenium

Browse
About
- About The Channel
- Content Partners